Contrasting Anthem (ANTM) & Magellan Health (MGLN)
Anthem (NYSE: ANTM) and Magellan Health (NASDAQ:MGLN) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations.
This table compares Anthem and Magellan Health’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings & Valuation
This table compares Anthem and Magellan Health’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Anthem||$88.03 billion||0.58||$5.75 billion||$10.56||18.32|
|Magellan Health||$5.28 billion||0.39||$242.58 million||$3.53||24.90|
Anthem has higher revenue and earnings than Magellan Health. Anthem is trading at a lower price-to-earnings ratio than Magellan Health, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
87.7% of Anthem shares are held by institutional investors. Comparatively, 93.5% of Magellan Health shares are held by institutional investors. 0.4% of Anthem shares are held by company insiders. Comparatively, 3.6% of Magellan Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Risk & Volatility
Anthem has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, Magellan Health has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500.
This is a summary of current recommendations and price targets for Anthem and Magellan Health, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Anthem currently has a consensus price target of $186.19, indicating a potential downside of 3.74%. Magellan Health has a consensus price target of $79.75, indicating a potential downside of 9.27%. Given Anthem’s stronger consensus rating and higher probable upside, equities analysts plainly believe Anthem is more favorable than Magellan Health.
Anthem pays an annual dividend of $2.80 per share and has a dividend yield of 1.4%. Magellan Health does not pay a dividend. Anthem pays out 26.5% of its earnings in the form of a dividend. Anthem has increased its dividend for 2 consecutive years.
Anthem beats Magellan Health on 13 of the 17 factors compared between the two stocks.
Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.
About Magellan Health
Magellan Health, Inc. is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).
Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.